{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:23:47Z","timestamp":1790601827659,"version":"4.1.0"},"reference-count":17,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2017,3,22]]},"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Recently a novel syndromic form of overgrowth with intellectual disability and distinct facial features was identified caused by constitutional mutations in the epigenetic regulator DNA-methyltransferase 3A (<jats:italic>DNMT3A<\/jats:italic>), referred to as Tatton-Brown-Rahman syndrome (TBRS). Somatically acquired mutations in <jats:italic>DNMT3A<\/jats:italic> occur in haematological malignancies and are frequently present in acute myeloid leukaemia (AML) affecting in more than 50% the arginine residue at position 882 (R882). To date, additional cases with TBRS have been published but so far none of the reported cases with TBRS developed AML.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>Here we present the first case of TBRS who developed AML at the age of 15 years. Whole-exome sequencing identified a constitutional heterozygous <jats:italic>DNMT3A<\/jats:italic> R882C mutation. Our case exhibits macrocephaly, intellectual disability, distinct facial dysmorphism and other recurrent features fitting with the TBRS phenotype. The AML of the myelomonocytic subtype harboured only few additional somatically acquired mutations, that is, an aberrant karyotype and a recurrent <jats:italic>PTPN11<\/jats:italic> mutation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>The peculiarity of the specific R882 mutation in contrast to other <jats:italic>DNMT3A<\/jats:italic> mutations is discussed, including the hypothesis of the more aggressive nature of this variant.<\/jats:p>\n                  <jats:p>Our case represents the first evidence of the possible increased risk of the development of haematological malignancies in particular AML in cases with TBRS.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jmedgenet-2017-104574","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T20:55:19Z","timestamp":1492808119000},"page":"805-808","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":33,"title":["Acute myeloid leukaemia in a case with Tatton-Brown-Rahman syndrome: the peculiar <i>DNMT3A<\/i> R882 mutation"],"prefix":"10.1136","volume":"54","author":[{"given":"Iris H I M","family":"Hollink","sequence":"first","affiliation":[{"name":"Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ans M W","family":"van den Ouweland","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H Berna","family":"Beverloo","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan T C J M","family":"Arentsen-Peters","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology\/Hematology, Erasmus Medical Center, Sophia Children\u2019s Hospital, Rotterdam, The Netherlands"},{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Michel","family":"Zwaan","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology\/Hematology, Erasmus Medical Center, Sophia Children\u2019s Hospital, Rotterdam, The Netherlands"},{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Wagner","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,4,21]]},"reference":[{"key":"2025101722262679000_54.12.805.1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31359"},{"key":"2025101722262679000_54.12.805.2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-346643"},{"key":"2025101722262679000_54.12.805.3","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2917"},{"key":"2025101722262679000_54.12.805.4","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2015-103638"},{"key":"2025101722262679000_54.12.805.5","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/ajmg.a.37588","article-title":"Tatton-Brown-Rahman syndrome due to 2p23 microdeletion","volume":"170A","author":"Okamoto","year":"2016","journal-title":"Am J Med Genet A"},{"key":"2025101722262679000_54.12.805.6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/cge.12878","article-title":"Novel DNMT3A germline mutations are associated with inherited Tatton-Brown-Rahman syndrome","volume":"91","author":"Xin","year":"2017","journal-title":"Clin Genet"},{"key":"2025101722262679000_54.12.805.7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ajmg.a.37995","article-title":"Acute myeloid leukemia-associated DNMT3A p.Arg882His mutation in a patient with Tatton-Brown-Rahman overgrowth syndrome as a constitutional mutation","volume":"173","author":"Kosaki","year":"2017","journal-title":"Am J Med Genet A"},{"key":"2025101722262679000_54.12.805.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005143"},{"key":"2025101722262679000_54.12.805.9","doi-asserted-by":"publisher","DOI":"10.1038\/ng.788"},{"key":"2025101722262679000_54.12.805.10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-631747"},{"key":"2025101722262679000_54.12.805.11","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003519","article-title":"DNMT3A R882 mutations predict a poor prognosis in AML: a meta-analysis from 4474 patients","volume":"95","author":"Yuan","year":"2016","journal-title":"Medicine"},{"key":"2025101722262679000_54.12.805.12","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.210"},{"key":"2025101722262679000_54.12.805.13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3892\/ol.2013.1347","article-title":"Gene expression profiling of the DNMT3A R882 mutation in acute leukemia","volume":"6","author":"Huang","year":"2013","journal-title":"Oncol Lett"},{"key":"2025101722262679000_54.12.805.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.02.010"},{"key":"2025101722262679000_54.12.805.15","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.038976"},{"key":"2025101722262679000_54.12.805.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409405"},{"key":"2025101722262679000_54.12.805.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408617"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmedgenet-2017-104574","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T05:26:35Z","timestamp":1760765195000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmedgenet-2017-104574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,21]]},"references-count":17,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,11,23]]},"published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.1136\/jmedgenet-2017-104574"],"URL":"https:\/\/doi.org\/10.1136\/jmedgenet-2017-104574","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,21]]}}}